Home Newsfeeds Loop Capital Maintains Hold on Workday, Raises Price Target to $180

Loop Capital Maintains Hold on Workday, Raises Price Target to $180

Loop Capital analyst Yun Kim maintains Workday (NASDAQ:WDAY) with a Hold and raises the price target from $160 to $180.

byBenzinga Newsdesk

February 28, 2023

1 minute read

Loop Capital analyst Yun Kim maintains Workday (NASDAQ:WDAY) with a Hold and raises the price target from $160 to $180.

European Union Ministers have been Advised to Take a Tougher Stance on China; Work Closely With U.S. to Strengthen Cyber Defense, Supply Chain

By Charles Gross

October 17, 4:50 AM

-FT https://www.ft.com/content/5be3f272-d689-4acc-97c2-9ebce41556b3

FXI

The Daily Biotech Pulse: Pfizer Inks Pact With Africa For COVID-19 Pills, Emergent Bio & Ridgeback To Increase Access To Ebola Treatment, ADC Therapeutics & Sobi In European Pact For Lymphoma Drug

By Vandana Singh

July 8, 8:19 AM

Here's a roundup of top developments in the biotech space over the last 24 hours:

ADCT

BlackBerry Q3 Adj. EPS $(0.05) Beats $(0.07) Estimate, Sales $169.00M Beat $168.73M Estimate

By Michael Horton

December 20, 6:05 PM

BlackBerry (NYSE:BB) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.07) by 28.57 percent. The company reported quarterly sales of $169.00 million which beat the analyst

US Companies In Japan Wary On Market Intervention As Yen Hits 34-Year Low Vs. Dollar

By Neil Dennis

March 27, 1:59 PM

The Japanese yen fell Wednesday to a 34-year low against the dollar, which is a boon for exporters, but imports are more expensive.

CVX

Loop Capital Maintains Hold on Workday, Raises Price Target to $180

Related Posts

European Union Ministers have been Advised to Take a Tougher Stance on China; Work Closely With U.S. to Strengthen Cyber Defense, Supply Chain

The Daily Biotech Pulse: Pfizer Inks Pact With Africa For COVID-19 Pills, Emergent Bio & Ridgeback To Increase Access To Ebola Treatment, ADC Therapeutics & Sobi In European Pact For Lymphoma Drug

BlackBerry Q3 Adj. EPS $(0.05) Beats $(0.07) Estimate, Sales $169.00M Beat $168.73M Estimate

US Companies In Japan Wary On Market Intervention As Yen Hits 34-Year Low Vs. Dollar